Table of Contents

Summary of Sites by Race and Sex: Counts
Summary of Sites by Race and Sex: Rates

Section 2

Summary of Sites by Stage
Table 2-1: Indiana Cases 1997 - 2001

Site Number* of Cases SEER** Summary Stage at Diagnosis
In Situ Local Regional Distant Unstaged
All Sites 144,93010,167 60,02931,665 29,83813,231
Oral Cavity and Pharynx 3,15574 1,2561,443 199183
Lip 32314 26914 422
Tongue 73617 289351 4336
Salivary Gland 3313 170116 2220
Floor of Mouth 26516 122109 513
Gum and Other Mouth 48012 224185 3029
Nasopharynx 1350 1190 2410
Tonsil 4396 83308 2715
Oropharynx 1111 2368 910
Hypopharynx 2323 49147 249
Other Oral Cavity and Pharynx 1032 1655 1119
Digestive System 27,7461,422 7,86110,084 5,9502,429
Esophagus 1,49535 352490 401217
Stomach 1,71416 368606 493231
Small Intestine 5294 140211 12747
Colon and Rectum 18,3591,281 5,9637,048 3,0621,005
Colon excluding Rectum 13,361902 4,1935,333 2,311622
Cecum 3,014149 8991,322 55688
Appendix 1290 4338 3810
Ascending Colon 2,265112 7271,000 34779
Hepatic Flexure 77026 220379 10837
Transverse Colon 1,17952 384512 18348
Splenic Flexure 45718 105243 8110
Descending Colon 67952 229281 9621
Sigmoid Colon 4,028414 1,4321,409 662111
Large Intestine, NOS 84079 154149 240218
Rectum and Rectosigmoid Junction 4,998379 1,7701,715 751383
Rectosigmoid Junction 1,39964 414570 29358
Rectum 3,599315 1,3561,145 458325
Anus, Anal Canal and Anorectum 47856 228116 3642
Liver and Intrahepatic Bile Duct 1,0600 328205 260267
Liver 8960 295162 232207
Intrahepatic Bile Duct 1640 3343 2860
Gallbladder 36018 94121 10621
Other Biliary 4087 93156 6290
Pancreas 2,9884 2491,060 1,232443
Retroperitoneum 1120 3938 2114
Peritoneum, Omentum and Mesentery 1700 623 11427
Other Digestive Organs 731 110 3625
Respiratory System 25,384143 5,7296,408 10,6762,428
Nose, Nasal Cavity and Middle Ear 2054 4596 3129
Larynx 1,56399 880452 6072
Lung and Bronchus 23,30140 4,7185,764 10,5212,258
Pleura 2770 7687 5361
Trachea, Mediastinum and Other Respiratory Organs 380 109 118
Bones and Joints 2730 12684 3924
Soft Tissue including Heart 8540 492144 12395
Skin excluding Basal and Squamous 5,6711,272 3,502371 210316
Melanoma of the Skin 5,2971,266 3,250346 169266
Other Non-Epithelial Skin 3746 25225 4150
Breast 24,8533,893 13,1636,123 1,022652
Female Genital System 9,405735 4,8021,633 1,825410
Cervix Uteri 1,4540 784480 11377
Corpus and Uterus, NOS 4,234100 3,036631 321146
Corpus Uteri 4,165100 3,018617 304126
Uterus, NOS 690 1814 1720
Ovary 2,4797 641361 1,326144
Vagina 19770 5747 1310
Vulva 943555 255100 1518
Other Female Genital Organs 983 2914 3715
Male Genital System 18,04552 13,3562,044 1,0211,572
Prostate 17,0360 12,6931,867 9331,543
Testis 8082 561143 8220
Penis 17448 8928 36
Other Male Genital Organs 272 136 33
Urinary System 10,5712,563 5,0451,337 1,095531
Urinary Bladder 6,1422,419 2,666562 203292
Kidney and Renal Pelvis 4,09662 2,240712 874208
Ureter 24359 11148 817
Other Urinary Organs 9023 2815 1014
Eye and Orbit 25411 19521 324
Brain and Other Nervous System 1,9500 1,440232 27251
Brain 1,8440 1,381217 21225
Cranial Nerves Other Nervous System 1060 5915 626
Endocrine System 1,9602 1,280465 14172
Thyroid Gland 1,7622 1,211418 8645
Other Endocrine including Thymus 1980 6947 5527
Lymphoma 6,2660 1,7361,273 2,410847
Hodgkin Lymphoma 8700 201374 22966
Hodgkin - Nodal 8520 194369 22366
Hodgkin - Extranodal 180 75 60
Non-Hodgkin Lymphoma 5,3960 1,535899 2,181781
NHL - Nodal 4,0090 832678 1,908591
NHL - Extranodal 1,3870 703221 273190
Myeloma 1,5350 410 1,44450
Leukemia 3,3720 00 3,28092
Lymphocytic Leukemia 1,5040 00 1,46638
Acute Lymphocytic Leukemia 4280 00 4280
Chronic Lymphocytic Leukemia 9640 00 93133
Other Lymphocytic Leukemia 1120 00 1075
Myeloid and Monocytic Leukemia 1,6770 00 1,65324
Acute Myeloid Leukemia 1,1290 00 1,11613
Acute Monocytic Leukemia 670 00 670
Chronic Myeloid Leukemia 4390 00 42910
Other Myeloid/Monocytic Leukemia 420 00 411
Other Leukemia 1910 00 16130
Other Acute Leukemia 1070 00 1016
Aleukemic, Subleukemic and NOS 840 00 6024
Miscellaneous 3,6360 53 3733,255

* Please note that these totals will not match those in Sections 3 and 4, as these numbers include all in situ cases, though basal and squamous skin cell cancers are still excluded.
** Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.


Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, February 2005

Summary of Sites by Race and Sex: Counts
Summary of Sites by Race and Sex: Rates

Table of Contents